ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
VBI Vaccines Inc
VBI Vaccines Inc
VBIV
時価総額
$154.7万
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
NET LOSS
-23
-39
-64
-55
-46
-70
-113
Depreciation and amortization
1
1
1
1
2
2
2
Stock-based compensation
3
2
3
4
5
10
10
Amortization of debt discount
0
1
1
1
2
3
2
Loss on extinguishment of long-term debt
-
-
-
-
-
-
-0
Inventory reserve
-
-
-
-
1
0
1
Unrealized foreign exchange loss (gain)
-
-
-
-
-
-
-27
Change in accounts receivable
-0
-0
-0
0
-0
-0
0
Change in inventory
0
0
0
0
2
1
6
Change in prepaid expenses
-
0
0
-0
1
1
-0
Change in other current assets
-0
0
-0
-0
8
-6
3
Change in other long-term assets
0
0
0
-0
-0
1
0
Change in operating right of use assets
-
-
-
-
-1
-1
-1
Change in accounts payable
0
-1
4
-5
2
0
9
Change in deferred revenues
-
-
5
-2
-1
-0
0
Change in other current liabilities
3
5
4
0
-1
11
-3
Payments made on operating lease liabilities
-
-
-
-
-
-
1
Net cash flows used in operating activities
-19
-31
-46
-49
-47
-40
-74
Purchase of property and equipment
1
1
6
4
1
2
4
Net cash flows used in/ provided by investing activities
2
-1
-6
-4
-26
23
-4
Proceeds from issuance of common shares for in financing transactions
24
72
47
40
122
33
-
Share issuance costs
-
5
3
3
6
1
-
Proceeds from issuance of common shares upon exercise of warrants
-
-
-
-
2
0
-
Proceeds from issuance of common shares upon exercise of stock options
0
0
0
-
0
0
0
Proceeds from debt financing
-
-
-
-
20
12
20
Debt issuance costs
-
-
-
-
1
0
1
Net cash flows provided by financing activities
36
67
44
37
122
44
19
Effect of exchange rates on cash
-
-
-1
-0
0
0
-0
CHANGE IN CASH FOR THE YEAR
-
-
-8
-15
50
28
-59
Interest paid
-
2
2
2
2
2
3
Adjustments for prior periods from adoption of ASU 2020-06
-
-
-
-
-
-
1
Warrant modification in connection with debt amendment
-
-
-
-
-
-1
-
Warrants issued in connection with financing transactions
-
-
-
-
-
-
2
Common shares issued in connection with cashless warrant exercise
-
-
-
-
-
4
-
Capital expenditures included in accounts payable and other current liabilities
-
-
-
-
-
0
0
Share issuance costs included in accounts payable and other current liabilities
-
-
-
-
-0
-0
0